about
Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung CancerCombination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal CancerSorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney CancerCapecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal CancerGoserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast CancerBioPoly RS Knee Registry Study for Cartilage Defect ReplacementEffects of Obesity Surgery on Renal FunctionInvestigation of Newly Developed Ostomy Products in Subjects With IleostomyA Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian CancerSingle-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone PainPredictive Model of Therapy Outcomes in Breast Cancer PatientsEuropean Sapheon™ Closure System Observational ProspectivE (eSCOPE) StudyThe Effects of Glycemic Optimization Before Gastric Bypass SurgeryCediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive GlioblastomaThis is an Extension Study of the Roche P-trial to Investigate Safety and Effectiveness of a Single Ocrelizumab Dose in Participants With Multiple Sclerosis (MS)A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene AberrationsMultiple Sclerosis-Simvastatin Trial 2Multicentre Observational Study Evaluating the Clinical Outcome of the H1 Ceramic Hip Resurfacing ArthroplastyPHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVFA Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseCarboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract CancerA Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical PracticeA Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IAn Open-Label Crenezumab Study in Patients With Alzheimer's Disease
P6153
Q58407576-9ADB3DAA-7157-40E2-9101-57AF6C86BDE3Q61914968-FA3A6045-129A-4A11-8DD7-45B7EAB07333Q61917903-5DA5CDB1-CF15-46B6-A4E6-3AEF0A80A672Q61921329-40DE1E52-1068-4E8C-91BA-492D126E8EC5Q61921368-EB64381B-4D3D-4BE9-B52B-5A0B5C9402A7Q61955369-44B2A103-D181-48FC-AA8F-E1790826A18DQ61956782-6238255D-CDBB-4870-B37B-F3BF353A6CE0Q61969732-05F263AD-FC73-440B-9CE9-B452A71FB2A0Q61969815-B57EF524-5055-4D5A-881F-E7738335A6B4Q62110797-B6BA4218-6AA0-4CFC-84B6-04C0A1AB3950Q62111085-2C949C85-2A40-441B-A8AD-7DB204D9072AQ63316041-218ADA6D-8387-4D4E-87AF-291EEB2FE048Q63317019-820F60EB-38EE-427C-8D95-23BD1604F297Q63333995-E0D21E0F-A34C-4838-AF02-26A0BE2C9F92Q63339251-B7312CBC-1578-435E-BABA-3BA361E838E9Q63394332-AD3E9D1A-8DE6-4614-B765-87F0C413CA61Q63405227-51FE2BA0-3A51-435E-A853-71B75D7AC7D5Q63405678-C9EEFC2A-19AB-4015-9E7C-FAD1AB0CDA3EQ63534243-D0B50CB6-B237-4F4F-B0FF-1956AC7E2AF2Q63535152-05CB2E01-3F5B-4B4E-BD05-BC71845F5FD2Q63574620-28740A0D-1302-466D-BD4D-F56831153926Q63576117-C85C4E33-26AC-4B7B-8A4C-932F2210774DQ64123622-E9D9FE85-4AA3-442F-8BF4-573CAA428A54Q64139347-01FB6EB5-E4E4-45A7-818C-8ACBA72F771CQ64151443-2A19853D-36AD-43F5-A38B-5A033A85D16BQ64184431-B3E586E1-79E1-4D73-AE37-5969CA727598
P6153
name
Charing Cross Hospital
@en
type
label
Charing Cross Hospital
@en
prefLabel
Charing Cross Hospital
@en
P1433
P1476
Charing Cross Hospital
@en
P577
1916-04-01T00:00:00Z